Who
Jacqueline K. Barton
Director
Company insider
Files Form 4 as: Director, Gilead Sciences; Director, Dow; Director, Dow Chemical Co /de/.
In numbers
- Trades disclosed
- 80
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $141K
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 6 Mar 2006
- Last trade
- 30 Apr 2026
- Last filed
- 4 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Apr 2026filed 4 May 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code A | —1,146 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,884 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,884 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code A | —1,146 at $0.00 | filing |
| 7 May 2025filed 8 May 2025 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,809 at $0.00 | filing |
| 7 May 2025filed 8 May 2025 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code A | —1,516 at $0.00 | filing |
| 8 May 2024filed 9 May 2024 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,648 at $0.00 | filing |
| 8 May 2024filed 9 May 2024 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code A | —2,310 at $0.00 | filing |
| 3 May 2023filed 4 May 2023 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | $808K10,173 at $79.45 | filing |
| 3 May 2023filed 4 May 2023 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code A | —1,887 at $0.00 | filing |
| 5 May 2022filed 6 May 2022 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,851 at $0.00 | filing |
| 5 May 2022filed 6 May 2022 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code A | —2,444 at $0.00 | filing |
| 3 May 2022filed 3 May 2022 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,223 | filing |
| 3 May 2022filed 3 May 2022 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code M | —2,223 | filing |
| 12 May 2021filed 14 May 2021 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,223 | filing |
| 12 May 2021filed 14 May 2021 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,665 at $0.00 | filing |
| 6 May 2021filed 7 May 2021 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,936 | filing |
| 6 May 2021filed 7 May 2021 | GILD Gilead SciencesBiotechnology | SEC FORM 4 Code M | —1,936 | filing |
| 6 May 2020filed 7 May 2020 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,936 | filing |
| 6 May 2020filed 7 May 2020 | GILD Gilead Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,886 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.